Non-interventional Study of Patients Using Norditropin® for Growth Hormone Deficiency or Turner Syndrome

A Multicentre, Open Label, Non-interventional Study to Evaluate on Long-term Safety and Efficacy of Norditropin® Formulation in Child Patients With GHD or Turner Short Stature Without Closure of Epiphyseal Discs.

This study is conducted in Japan. The aim of this study is to collect information about the efficacy and safety of Norditropin® (somatropin) in the long-term treatment of short stature with GHD (Growth Hormone Deficiency) where epiphysial discs are not closed and short stature with Turner Syndrome where epiphysial discs are not closed.

Inclusion Criteria:

• Growth hormone deficiency or short stature due to Turner Syndrome where the epiphyseal discs are not closed

Exclusion Criteria:

• Diabetic
• Patients with malignant tumors
• Women who are either pregnant or likely to be pregnant
• Known or suspected allergy to study product(s) or related products